Form 4: Myomo Chief Medical Officer Harry Kovelman Sells 35,426 Shares
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 35,426 shares of common stock at an average price of $3.6933 on May 15, 2024.
Summary
- On May 15, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 35,426 shares of the company's common stock.
- The shares were sold at an average price of $3.6933 per share.
- Following the transaction, Kovelman directly owns 98,009 shares of Myomo, Inc.
- The sales were transacted in multiple lots at prices ranging from $3.60 to $3.76 per share.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider stock sale. The sale itself doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of an insider transaction. It's important to monitor insider trading activity as it can sometimes provide insights into management's perspective on the company's future prospects, although this sale alone doesn't necessarily indicate a negative outlook.
Stakeholder Impact
- The sale of shares by a high-ranking officer could potentially create uncertainty among shareholders, although the impact is likely to be minimal given the size of the transaction relative to the company's overall market capitalization.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of the stock sale transaction. |
| 05/17/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.